Interaction of New, Very Potent Non-Nucleotide Antagonists with Arg256 of the Human Platelet P2Y12 Receptor

SOME QUANTITATIVE USES OF DRUG ANTAGONISTS

O. ARUNLAKSHANA, H. O. Schild · British Journal of Pharmacology and Chemotherapy · 1959 · 4K citations · Full text

Medicine, Pharmacology, General Pharmacology +16

Identification and Biological Activity of the Active Metabolite of Clopidogrel

Pierre Savi, Jean‐Marie Pereillo, Marie-Françoise Uzabiaga et al. · Thrombosis and Haemostasis · 2000 · 748 citations

Medicine, Medicinal Chemistry, Pharmacology +17

The active metabolite of Clopidogrel disrupts P2Y12 receptor oligomers and partitions them out of lipid rafts

Pierre Savi, Jean‐Luc Zachayus, Nathalie Delesque-Touchard et al. · Proceedings of the National Academy of Sciences · 2006 · 318 citations · Full text

Medicine, Biochemistry, Pharmacology +17

Antagonists of the Platelet P<i>_2T</i> Receptor:  A Novel Approach to Antithrombotic Therapy

Anthony H. Ingall, John Dixon, Andrew Bailey et al. · Journal of Medicinal Chemistry · 1999 · 285 citations

Medicine, Medicinal Chemistry, Pharmacology +17

P₂‐purinoceptors of two subtypes in the rabbit mesenteric artery: reactive blue 2 selectively inhibits responses mediated via the P_2y‐ but not the P_2x‐purinoceptor

Geoffrey Burnstock, Jennifer J.I. Warland · British Journal of Pharmacology · 1987 · 245 citations · Full text

Medicine, Pharmacology, Physiology +16